Latest Manufacturing Expansion News

6K Additive has completed a six-year, US$27.4 million secured loan with the US Export-Import Bank to expand production of critical metal powders in Pennsylvania. The financing gives the company access to project funding through June 2028, but the final interest rate and the expansion’s eventual output remain to be established.

Li-S Energy has narrowed its FY26 loss and reached several commercialisation milestones, including a 2C Power Cell, international shipping approvals and its first lithium foil sale. But the ASX battery developer still needs customer offtake and fresh funding before its proposed 1 GWh manufacturing expansion can become reality.

Waterco Limited (ASX:WAT) delivered record FY26 EBIT of $23.8 million and lifted net profit after tax 59.6% to $15.4 million, despite only modest revenue growth. The stronger result supports a higher fully franked dividend, but the group is carrying more debt and inventory as it expands manufacturing capacity.

Boresight Ltd’s US subsidiary has landed a US$383,275 purchase order from a repeat North American military customer, tripling previous drone orders and expanding its footprint in counter-drone training.

Orthocell posts record FY26 revenue growth driven by expanding US and international sales of its collagen medical devices, while investing ahead in manufacturing capacity and product pipeline.

Boresight Ltd (ASX: BST) recorded a 46% increase in revenue to $6.38 million for FY26, driven by global sales expansion and strategic investments including an $8 million IPO. Despite this growth, the company posted a $6.66 million net loss, largely due to increased operational expenses and significant share-based payments.

SomnoMed reported a 3% revenue rise to $114.5 million and a 19% EBITDA increase to $10.9 million in FY26, navigating European market headwinds and a CEO transition while launching its Virtus device targeting sleep apnea with bruxism.

PolyNovo reported a 16.1% rise in FY26 revenue to AUD 150 million, driven by strong global sales and manufacturing expansion, yet net profit fell 44% due to a significant asset write-off from an R&D centre fire and lower tax benefits.

DXN Limited has landed a A$12.2 million contract to deliver a 2MW AI High-Performance Computing modular data centre, expanding its AI HPC order book to about A$21 million and positioning the company for further growth in a booming market.

Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.

Adrad Holdings delivered a 15% rise in net profit after tax for FY26, driven by operational efficiency and growth in engineered heat transfer solutions, alongside a 15% dividend increase.

CSL Limited’s FY2026 results reveal modest revenue growth offset by a multibillion-dollar statutory loss driven by restructuring and impairments, alongside a maintained dividend and a strategic focus on sustainable growth.